General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...
Tumor molecular pathology is an evolving field dedicated to uncovering the molecular underpinnings of cancer development and progression. This discipline ...